Pharma giant Roche is buying cancer tech startup Flatiron Health for $1.9 billion (ROG)

pulse

February 15, 2018 9:56 PM

The New York-based cancer technology startup had previously been valued at $1.2 billion after raising $175 million from investors including Roche.

Pharma giant Roche is acquiring Flatiron Health for $1.9 billion.
The
Flatiron collects clinical data from cancer patients — such as what medications patients have taken and how they have responded to them.

Roche is buying Flatiron Health.

New York-based healthcare technology startup

partnered with the Food and Drug Administration

pulse

Enhance Your Pulse News Experience!

Get rewards worth up to $20 when selected to participate in our exclusive focus group. Your input will help us to make informed decisions that align with your needs and preferences.

I've got feedback!

JOIN OUR PULSE COMMUNITY!

Unblock notifications in browser settings.

Eyewitness? Submit your stories now via social or:

Email: eyewitness@pulse.ng